Pfizer’s Wyeth Settles Effexor XR Antitrust Case for $39 Million
Pfizer subsidiary Wyeth has agreed to a $39 million settlement in a long-standing antitrust case related to its antidepressant drug…
pharmaceutical industry
Pfizer Settles Antitrust Claims for $93 Million
Background Pfizer (PFE.N) has agreed to a settlement of $93 million to resolve antitrust allegations brought forth by wholesale drug…
Novartis Announces Acquisition of MorphoSys for $2.9 Billion
In a strategic move aimed at bolstering its cancer treatment portfolio, Novartis AG has declared its intention to acquire MorphoSys…
McKinsey & Co Agrees to $78 Million Settlement in Opioid Epidemic Case
Global Consulting Firm Settles Claims Linked to Opioid Crisis In a landmark development, consulting giant McKinsey & Co has reached…
Biden Administration Unveils New Policy to Seize Patents on Government-Funded Medicines
In a groundbreaking move, the Biden Administration announced on Thursday its intention to implement a new policy that empowers the…
Pharmaceutical Industry Gears Up for Second Wave of Legal Challenges Against Medicare Drug Pricing
PhRMA CEO Stephen Ubl Anticipates Renewed Legal Offensive In a recent discussion with Bloomberg Law, the CEO of the Pharmaceutical…
Life Sciences Coalition Opposes Federal Antitrust Deal Review Changes
A New Coalition Emerges A coalition comprising Amgen Inc., Gilead Sciences Inc., Novartis AG, Merck & Co., AbbVie Inc., and…
Championing Justice: How a Leading Law Firm Fights Pharmaceutical Patent Abuse with Remarkable Success
The law firm of Smith, Johnson, and Lee has been providing top-notch legal services to clients for over 50 years.…
Greenberg Traurig At The Helm Of Huge Pharmaceutical Merger
PRWeb: The Miami-based firm, Greenberg Traurig is playing financial advisor to Valeant Pharmaceuticals in a merger deal with Biovail. The…